Two Sigma Advisers’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.37M | Sell |
|
|||||
|
2025
Q1 | $7.87M | Sell |
|
|||||
|
2024
Q4 | $17.5M | Sell |
|
|||||
|
2024
Q3 | $15.1M | Sell |
|
|||||
|
2024
Q2 | $22.6M | Sell |
|
|||||
|
2024
Q1 | $22.5M | Sell |
|
|||||
|
2023
Q4 | $24.4M | Buy |
|
|||||
|
2023
Q3 | $14.9M | Buy |
|
|||||
|
2023
Q2 | $2.93M | Buy |
|
|||||
|
2023
Q1 | $3.37M | Sell |
|
|||||
|
2022
Q4 | $10.4M | Sell |
|
|||||
|
2022
Q3 | $13.8M | Sell |
|
|||||
|
2022
Q2 | $14.7M | Sell |
|
|||||
|
2022
Q1 | $22.2M | Sell |
|
|||||
|
2021
Q4 | $22.8M | Sell |
|
|||||
|
2021
Q3 | $38M | Buy |
|
|||||
|
2021
Q2 | $69.9M | Sell |
|
|||||
|
2021
Q1 | $59.7M | Sell |
|
|||||
|
2020
Q4 | $83.2M | Sell |
|
|||||
|
2020
Q3 | $72.8M | Sell |
|
|||||
|
2020
Q2 | $52.5M | Buy |
|
|||||
|
2020
Q1 | $42M | Sell |
|
|||||
|
2019
Q4 | $75.3M | Sell |
|
|||||
|
2019
Q3 | $66.9M | Buy |
|
|||||
|
2019
Q2 | $38.7M | Buy |
|
|||||
|
2019
Q1 | $25.6M | Buy |
|
|||||
|
2018
Q4 | $8.22M | Sell |
|
|||||
|
2018
Q3 | $19M | Buy |
|
|||||
|
2018
Q2 | $7.71M | Buy |
|
|||||
|
2018
Q1 | $680K | Buy |
|
|||||
|
2017
Q4 | $211K | Buy |
|